Report Reveals Dramatic Revenue and Executive Pay Increases in 340B Drug Pricing Program
TL;DR
Executives of 340B-eligible entities saw a 237.11% increase in compensation, providing a significant advantage in financial growth.
The report on the 340B Drug Pricing Program reveals a detailed analysis of annual revenue and executive compensation trends.
The 340B Program aims to benefit patients, but the report highlights the need to prioritize patient care over executive compensation and profit.
The 340B Executive Compensation Report sheds light on discrepancies in charity care provision and revenue increases among covered entities.
Found this article helpful?
Share it with your network and spread the knowledge!
A new report from ADAP Advocacy and the Community Access National Network reveals substantial financial transformations within the 340B Drug Pricing Program, raising critical questions about program effectiveness and patient-focused healthcare delivery.
The comprehensive audit of 33 covered entities uncovered striking financial trends. Organizations experienced an average revenue increase of 772.92%, while executive compensation rose by 237.11%. Simultaneously, these entities decreased their charity care provision by 34.80% relative to annual revenues.
The study examined 15 hospitals, 3 sexually transmitted disease clinics, and 15 HRSA-funded health centers. Brandon M. Macsata, ADAP Advocacy's CEO, criticized the program's current trajectory, suggesting that the original patient-centric intent has been compromised by financial prioritization of provider interests.
The report raises significant concerns about the 340B Drug Pricing Program's implementation. While the program was designed to support patient access to critical healthcare services, particularly for individuals living with HIV, the data suggests a potential misalignment between program objectives and actual outcomes.
These findings underscore the need for increased transparency, accountability, and potential regulatory oversight to ensure that healthcare programs genuinely serve patient needs rather than becoming vehicles for institutional financial expansion.
Curated from 24-7 Press Release
